These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 34724066)

  • 1. Changes in excess mortality among adults with diabetes-related end-stage kidney disease: a comparison between the USA and Australia.
    Harding JL; Morton JI; Shaw JE; Patzer RE; McDonald SP; Magliano DJ
    Nephrol Dial Transplant; 2022 Sep; 37(10):2004-2013. PubMed ID: 34724066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in Incidence of ESKD in People With Type 1 and Type 2 Diabetes in Australia, 2002-2013.
    Koye DN; Magliano DJ; Reid CM; Pavkov ME; Chadban SJ; McDonald SP; Polkinghorne KR; White S; Paul C; Shaw JE
    Am J Kidney Dis; 2019 Mar; 73(3):300-308. PubMed ID: 30579709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Association Between Age of Onset of Type 2 Diabetes and the Long-term Risk of End-Stage Kidney Disease: A National Registry Study.
    Morton JI; Liew D; McDonald SP; Shaw JE; Magliano DJ
    Diabetes Care; 2020 Aug; 43(8):1788-1795. PubMed ID: 32540924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increases in renal replacement therapy in Australia and New Zealand: understanding trends in diabetic nephropathy.
    Grace BS; Clayton P; McDonald SP
    Nephrology (Carlton); 2012 Jan; 17(1):76-84. PubMed ID: 21854505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type 2 diabetes in patients with end-stage kidney disease: influence on cardiovascular disease-related mortality risk.
    Lim WH; Johnson DW; Hawley C; Lok C; Polkinghorne KR; Roberts MA; Boudville N; Wong G
    Med J Aust; 2018 Nov; 209(10):440-446. PubMed ID: 30332936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of type 2 diabetes on mortality risk associated with end-stage kidney disease.
    Villar E; Polkinghorne KR; Chang SH; Chadban SJ; McDonald SP
    Diabetologia; 2009 Dec; 52(12):2536-41. PubMed ID: 19756481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absolute risk and risk factors for stroke mortality in patients with end-stage kidney disease (ESKD): population-based cohort study using data linkage.
    De La Mata NL; Alfaro-Ramirez M; Kelly PJ; Masson P; Al-Shahi Salman R; Webster AC
    BMJ Open; 2019 Feb; 9(2):e026263. PubMed ID: 30798318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained Lower Incidence of Diabetes-Related End-Stage Kidney Disease Among American Indians and Alaska Natives, Blacks, and Hispanics in the U.S., 2000-2016.
    Burrows NR; Zhang Y; Hora I; Pavkov ME; Sheff K; Imperatore G; Bullock AK; Albright AL
    Diabetes Care; 2020 Sep; 43(9):2090-2097. PubMed ID: 32616609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excess all-cause and cause-specific mortality for people with diabetes and end-stage kidney disease.
    Morton JI; Sacre JW; McDonald SP; Magliano DJ; Shaw JE
    Diabet Med; 2022 Jun; 39(6):e14775. PubMed ID: 34951712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. End-stage kidney disease due to Alport syndrome: outcomes in 296 consecutive Australia and New Zealand Dialysis and Transplant Registry cases.
    Mallett A; Tang W; Clayton PA; Stevenson S; McDonald SP; Hawley CM; Badve SV; Boudville N; Brown FG; Campbell SB; Johnson DW
    Nephrol Dial Transplant; 2014 Dec; 29(12):2277-86. PubMed ID: 25061124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer Mortality in People Receiving Dialysis for Kidney Failure: An Australian and New Zealand Cohort Study, 1980-2013.
    Rosales BM; De La Mata N; Vajdic CM; Kelly PJ; Wyburn K; Webster AC
    Am J Kidney Dis; 2022 Oct; 80(4):449-461. PubMed ID: 35500725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cause of death for people with end-stage kidney disease withdrawing from treatment in Australia and New Zealand.
    Khou V; De La Mata NL; Morton RL; Kelly PJ; Webster AC
    Nephrol Dial Transplant; 2021 Jul; 36(8):1527-1537. PubMed ID: 32750144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. End-stage kidney disease due to haemolytic uraemic syndrome--outcomes in 241 consecutive ANZDATA registry cases.
    Tang W; Mohandas J; McDonald SP; Hawley CM; Badve SV; Boudville N; Brown FG; Clayton PA; Wiggins KJ; Bannister KM; Campbell SB; Johnson DW
    BMC Nephrol; 2012 Dec; 13():164. PubMed ID: 23206870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemodialysis withdrawal in Australia and New Zealand: a binational registry study.
    Chan S; Marshall MR; Ellis RJ; Ranganathan D; Hawley CM; Johnson DW; Wolley MJ
    Nephrol Dial Transplant; 2020 Apr; 35(4):669-676. PubMed ID: 31397483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes of patients with end-stage kidney disease due to membranous nephropathy: A cohort study using the Australia and New Zealand Dialysis and Transplant Registry.
    Yang WL; Bose B; Zhang L; Mcstea M; Cho Y; Fahim M; Hawley CM; Pascoe EM; Johnson DW
    PLoS One; 2019; 14(8):e0221531. PubMed ID: 31442267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and survival of end-stage kidney disease due to polycystic kidney disease in Australia and New Zealand (1963-2014).
    Fernando MR; Dent H; McDonald SP; Rangan GK
    Popul Health Metr; 2017 Feb; 15(1):7. PubMed ID: 28212688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidences, treatments, outcomes, and sex effect on survival in patients with end-stage renal disease by diabetes status in Australia and New Zealand (1991 2005).
    Villar E; Chang SH; McDonald SP
    Diabetes Care; 2007 Dec; 30(12):3070-6. PubMed ID: 17848610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Social disparities in the prevalence of diabetes in Australia and in the development of end stage renal disease due to diabetes for Aboriginal and Torres Strait Islanders in Australia and Maori and Pacific Islanders in New Zealand.
    Hill K; Ward P; Grace BS; Gleadle J
    BMC Public Health; 2017 Oct; 17(1):802. PubMed ID: 29020957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].
    Antonucci F; Camerin E; Feriani M; Nordio M; Piccoli A; Rossi B; Tessitore N
    G Ital Nefrol; 2009; 26 Suppl 48():S5-56. PubMed ID: 19927265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcomes of end-stage kidney disease for patients with IgA nephropathy: A multi-centre registry study.
    Zhang L; Liu X; Pascoe EM; Badve SV; Boudville NC; Clayton PA; De Zoysa J; Hawley CM; Kanellis J; McDonald SP; Peh CA; Polkinghorne KR; Johnson DW
    Nephrology (Carlton); 2016 May; 21(5):387-96. PubMed ID: 26393772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.